Latest News and Press Releases
Want to stay updated on the latest news?
-
CAMBRIDGE, Mass., May 18, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative drug discovery and development company, today announced the promotion of Vito J....
-
CAMBRIDGE, Mass., May 6, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative drug discovery and development company, today reported recent research and development...
-
CAMBRIDGE, Mass., April 29, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative drug discovery and development company, announced today that management will host a...
-
-- Infinity Advances Hedgehog Pathway Inhibitor Into Later Clinical Development -- -- New Preclinical Data in Several Cancer Indications Further Support Broad Therapeutic Potential of IPI-926 --...
-
Infinity to Present New Preclinical Data From Its Hedgehog Pathway Inhibitor Program at AACR Meeting
CAMBRIDGE, Mass., April 8, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative drug discovery and development company, today announced that members of its scientific...
-
-- Julian Adams, Ph.D., President of R&D and CSO, to Present at New York City Academy of Sciences' "Hedgehog Pathway in Cancer" Symposium -- -- Infinity Scientists Also to Discuss Hedgehog...
-
CAMBRIDGE, Mass., March 2, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Gerald E. Quirk,...
-
CAMBRIDGE, Mass., Feb. 23, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that presentations...
-
Clinical Investigation Initiated for IPI-940 With Broad Potential in Neuropathic and Inflammatory Pain Financially Strong With Sufficient Capital to Fund Its Operating Plan Into 2013 CAMBRIDGE,...
-
CAMBRIDGE, Mass., Feb. 3, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced today that management will host...